Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonism
Identifieur interne : 002B72 ( Main/Exploration ); précédent : 002B71; suivant : 002B73Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonism
Auteurs : Eldad Melamed [États-Unis] ; Franz Hefti [États-Unis] ; Richard J. Wurtman [États-Unis]Source :
- Annals of Neurology [ 0364-5134 ] ; 1980-12.
Abstract
In intact striatum, the enzyme dopa decarboxylase is localized predominantly in dopaminergic nerve terminals. In Parkinson disease, loss of dopaminergic neurons is associated with massive depletion of striatal decarboxylase activity. Nevertheless, efficacy of exogenous L‐dopa in parkinsonism is generally believed to result from its enzymatic decarboxylation to dopamine in the corpus striatum. It has previously been suggested that, after degeneration of nigrostriatal pathways, decarboxylation of administered L‐dopa may occur mainly at such striatal sites as surviving dopaminergic terminals, serotonergic neurons, or capillaries; but currently available data do not favor these hypotheses. Recent experimental studies indicate that a substantial amount of decarboxylase activity is localized in striatal interneurons or efferent neurons that may not normally synthesize monoamines. We propose that after depletion of dopaminergic terminals, these nonaminergic striatal neurons may contain a large fraction of residual dopa decarboxylase activity and may represent an important locus for conversion of administered dopa to functional dopamine in the parkinsonian corpus striatum.
Url:
DOI: 10.1002/ana.410080603
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonism</title><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name></author><author><name sortKey="Hefti, Franz" sort="Hefti, Franz" uniqKey="Hefti F" first="Franz" last="Hefti">Franz Hefti</name></author><author><name sortKey="Wurtman, Richard J" sort="Wurtman, Richard J" uniqKey="Wurtman R" first="Richard J." last="Wurtman">Richard J. Wurtman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5957CB6313EEF5BB7E7116CEF70A3C307865A6F6</idno><date when="1980" year="1980">1980</date><idno type="doi">10.1002/ana.410080603</idno><idno type="url">https://api.istex.fr/document/5957CB6313EEF5BB7E7116CEF70A3C307865A6F6/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002750</idno><idno type="wicri:Area/Main/Curation">002407</idno><idno type="wicri:Area/Main/Exploration">002B72</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonism</title><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge</wicri:cityArea></affiliation></author><author><name sortKey="Hefti, Franz" sort="Hefti, Franz" uniqKey="Hefti F" first="Franz" last="Hefti">Franz Hefti</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge</wicri:cityArea></affiliation></author><author><name sortKey="Wurtman, Richard J" sort="Wurtman, Richard J" uniqKey="Wurtman R" first="Richard J." last="Wurtman">Richard J. Wurtman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Neurology</title><title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title><title level="j" type="abbrev">Ann Neurol.</title><idno type="ISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1980-12">1980-12</date><biblScope unit="volume">8</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="558">558</biblScope><biblScope unit="page" to="563">563</biblScope></imprint><idno type="ISSN">0364-5134</idno></series><idno type="istex">5957CB6313EEF5BB7E7116CEF70A3C307865A6F6</idno><idno type="DOI">10.1002/ana.410080603</idno><idno type="ArticleID">ANA410080603</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0364-5134</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In intact striatum, the enzyme dopa decarboxylase is localized predominantly in dopaminergic nerve terminals. In Parkinson disease, loss of dopaminergic neurons is associated with massive depletion of striatal decarboxylase activity. Nevertheless, efficacy of exogenous L‐dopa in parkinsonism is generally believed to result from its enzymatic decarboxylation to dopamine in the corpus striatum. It has previously been suggested that, after degeneration of nigrostriatal pathways, decarboxylation of administered L‐dopa may occur mainly at such striatal sites as surviving dopaminergic terminals, serotonergic neurons, or capillaries; but currently available data do not favor these hypotheses. Recent experimental studies indicate that a substantial amount of decarboxylase activity is localized in striatal interneurons or efferent neurons that may not normally synthesize monoamines. We propose that after depletion of dopaminergic terminals, these nonaminergic striatal neurons may contain a large fraction of residual dopa decarboxylase activity and may represent an important locus for conversion of administered dopa to functional dopamine in the parkinsonian corpus striatum.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name></region><name sortKey="Hefti, Franz" sort="Hefti, Franz" uniqKey="Hefti F" first="Franz" last="Hefti">Franz Hefti</name><name sortKey="Wurtman, Richard J" sort="Wurtman, Richard J" uniqKey="Wurtman R" first="Richard J." last="Wurtman">Richard J. Wurtman</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B72 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B72 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5957CB6313EEF5BB7E7116CEF70A3C307865A6F6
|texte= Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonism
}}
| This area was generated with Dilib version V0.6.23. |  |